Neve Ilan, Israel — July, 2020 – NANO-X IMAGING LTD (www.nanox.vision) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces it has secured a $110 million equity investment from global investors. Funds raised are planned to primarily support the rollout of the Nanox.ARC deployments worldwide.

Israeli-based A-Labs Advisory and Finance Ltd. were lead advisors to the round.

Nanox has signed agreements for the deployment of its innovative medical imaging system and diagnostics services in 13 countries across 5 continents. The Company plans to revolutionize early-detection healthcare via deployment of a global medical imaging infrastructure at an affordable price-per-scan service model while maximizing availability and accessibility of the service to all socio-economic communities.
“It is easy to say that we are aiming to change the world,” says Ran Poliakine, Founder and Chief Executive Officer of Nanox. “the main challenge with such statements is always the execution. We have a bold vision of helping to eradicate cancer and other disease by means of early detection. We are actively working for the deployment of a global medical imaging service infrastructure that may turn this dream into reality. We cannot do it without partners and investors who share our vision and support our plan. I thank our friends at SK Telecom, Foxconn, Industrial Alliance and Yozma Korea for their faith and trust in the Nanox team and vision.”


About Nanox
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.

X-Ray Homepage